NASDAQ: GLMDGalmed Pharmaceuticals Ltd Stock Ownership - Who owns Galmed Pharmaceuticals?
Insider buying vs selling
Have Galmed Pharmaceuticals Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GLMD insiders and whales buy or sell their stock.
GLMD Shareholders
What type of owners hold Galmed Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Allen Baharaff | 1.52% | 100,018 | $61.21k | Insider |
| Two Sigma Investments LP | 1.22% | 80,177 | $49.07k | Institution |
| Guy Nehemya | 0.38% | 25,000 | $15.30k | Insider |
| Yohai Stenzler | 0.38% | 25,000 | $15.30k | Insider |
| Doron Leib Cohen | 0.38% | 25,000 | $15.30k | Insider |
| Xtx Topco Ltd | 0.34% | 22,396 | $13.71k | Institution |
| Jane Street Group LLC | 0.25% | 16,445 | $10.06k | Institution |
| David Sidransky | 0.19% | 12,500 | $7.65k | Insider |
| Amir Poshinski | 0.19% | 12,500 | $7.65k | Insider |
| Shmuel Nir | 0.19% | 12,500 | $7.65k | Insider |
GLMD vs Biotech Stocks
Galmed Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.